Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 1/20 | 0.55 |
| ▸ | MALT1 | Q9UDY8 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | HTT | P42858 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | FBP1 | P09467 | 1/20 | 0.41 |
| ▸ | PSEN1 | P49768 | 2/20 | 0.41 |
| ▸ | PSEN2 | P49810 | 2/20 | 0.41 |
| ▸ | APH1B | Q8WW43 | 2/20 | 0.41 |
| ▸ | NCSTN | Q92542 | 2/20 | 0.41 |
| ▸ | APH1A | Q96BI3 | 2/20 | 0.41 |
| ▸ | PSENEN | Q9NZ42 | 2/20 | 0.41 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.41 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6801536 | 0.77 | PSEN1 (0.42) | HTR6MALT1KMT2ASMN1; SMN2MEN1 | |
| SCHEMBL3663503 | 0.77 | MAPT (0.51) | KMT2ASMN1; SMN2MEN1HTTTSHR | |
| SCHEMBL7566288 | 0.76 | CDK1 (0.45) | HTR6MALT1KMT2ASMN1; SMN2MEN1 | |
| SCHEMBL3933822 | 0.74 | FBP1 (0.49) | KMT2ASMN1; SMN2MEN1HTTTSHR | |
| SCHEMBL265540 | 0.74 | FBP1 (0.52) | HTR6KMT2ASMN1; SMN2MEN1HTT | |
| SCHEMBL682128 | 0.73 | MAPT (0.63) | HTR6KMT2ASMN1; SMN2MEN1HTT | |
| SCHEMBL6915023 | 0.73 | LMNA (0.37) | HTR6MALT1KMT2ASMN1; SMN2MEN1 | |
| SCHEMBL3933827 | 0.73 | FBP1 (0.48) | KMT2ASMN1; SMN2MEN1HTTTSHR | |
| SCHEMBL195598 | 0.72 | P2RY12 (0.53) | HTR6KMT2ASMN1; SMN2MEN1HTT | |
| SCHEMBL6804436 | 0.72 | KMT2A (0.49) | HTR6KMT2ASMN1; SMN2MEN1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040010142-A1 | Novel process | NOVO NORDISK A/S (DK) | 2004-01-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040010142-A1 | Novel process | UGT1A1, CYP4X1, CYP4B1 | HTR6 3080/4885MALT1 3625/4885KMT2A 4646/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.